Tokyo Tape
Sign in
← Medinet

Annual report

2370.TEDINET S100PT7B
Period2021-10-01 → 2022-09-30
Filed2022-12-15
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 92
MetricValuePeriodScopeSource row
Revenue¥634m2021-10-01 → 2022-09-30StandaloneNet sales
Revenue¥683m2020-10-01 → 2021-09-30StandaloneNet sales
Revenue¥783m2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Revenue¥1.1bn2018-10-01 → 2019-09-30dStandaloneNet sales (5-year summary)
Revenue¥998m2017-10-01 → 2018-09-30dStandaloneNet sales (5-year summary)
Revenue¥958m2017-10-01 → 2018-09-30dStandaloneNet sales (5-year summary)
Operating income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOperating income
Operating income−¥1.1bn2020-10-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥871m2020-10-01 → 2021-09-30StandaloneOrdinary income
Ordinary income−¥837m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥995m2018-10-01 → 2019-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2021-10-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥838m2020-10-01 → 2021-09-30StandaloneIncome before income taxes
Net income (owners)−¥3.0bn2017-10-01 → 2018-09-30dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income−¥1.3bn2021-10-01 → 2022-09-30StandaloneProfit loss
Net income−¥843m2020-10-01 → 2021-09-30StandaloneProfit loss
Net income−¥842m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Net income−¥795m2018-10-01 → 2019-09-30dStandaloneNet income loss (5-year summary)
Net income−¥3.1bn2017-10-01 → 2018-09-30dStandaloneNet income loss (5-year summary)
Total assets¥6.1bnat 2022-09-30StandaloneAssets
Total assets¥5.4bnat 2021-09-30StandaloneAssets
Total assets¥5.2bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.1bnat 2019-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.9bnat 2018-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.9bnat 2018-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥566mat 2022-09-30StandaloneLiabilities
Total liabilities¥475mat 2021-09-30StandaloneLiabilities
Net assets / equity¥5.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥4.9bnat 2021-09-30StandaloneNet assets
Net assets / equity¥4.8bnat 2020-09-30dStandaloneNet assets
Net assets / equity¥2.6bnat 2019-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥3.3bnat 2018-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥3.3bnat 2018-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥4.1bnat 2021-09-30StandaloneCash and deposits
Cash & equivalents¥4.5bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥4.1bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.6bnat 2020-09-30dStandaloneCash and cash equivalents
Cash & equivalents¥1.4bnat 2019-09-30dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.2bnat 2018-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.2bn2021-10-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥975m2020-10-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥633m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥938m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥2.5bn2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥20m2021-10-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥344m2020-10-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥86m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥50m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥154m2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.6bn2021-10-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2020-10-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.8bn2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥90m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-6.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.882020-10-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.192019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.712018-10-01 → 2019-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-26.772017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-27.472017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥26.03at 2022-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥27.31at 2021-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥29.6at 2020-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥21.1at 2019-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥27.56at 2018-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥27.03at 2018-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio90.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.8%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.7%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.7%at 2019-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.8%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.7%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE-24.1%2021-10-01 → 2022-09-30StandaloneRate of return on equity (5-year summary)
ROE-17.5%2020-10-01 → 2021-09-30StandaloneRate of return on equity (5-year summary)
ROE-23.0%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
ROE-27.7%2018-10-01 → 2019-09-30dStandaloneRate of return on equity (5-year summary)
ROE-70.0%2017-10-01 → 2018-09-30dStandaloneRate of return on equity (5-year summary)
ROE-72.2%2017-10-01 → 2018-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued211,730,423at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued178,750,423at 2021-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued160,830,423at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued120,875,423at 2019-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued118,230,423at 2018-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees96at 2022-09-30StandaloneNumber of employees
Employees83at 2021-09-30StandaloneNumber of employees
Employees78at 2020-09-30dStandaloneNumber of employees
Employees76at 2019-09-30dStandaloneNumber of employees
Employees92at 2018-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2021-10-01 → 2022-09-30¥13m
Reconciling Itemsreconcilingdepreciation2021-10-01 → 2022-09-30¥22m
Reconciling Itemsreconcilingsegment assetsat 2022-09-30¥5.3bn
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-09-30−¥518m
Cellular And Tissue Based Product Businessreportable segmentcapex2021-10-01 → 2022-09-30¥4m
Cellular And Tissue Based Product Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥28m
Cellular And Tissue Based Product Businessreportable segmentemployeesat 2022-09-3019 pure
Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥221,000
Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥221,000
Cellular And Tissue Based Product Businessreportable segmentsegment assetsat 2022-09-30¥147m
Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2022-09-30−¥582m
Contracted Cell Manufacturing Businessreportable segmentcapex2021-10-01 → 2022-09-30¥60m
Contracted Cell Manufacturing Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥56m
Contracted Cell Manufacturing Businessreportable segmentemployeesat 2022-09-3065 pure
Contracted Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥633m
Contracted Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥633m
Contracted Cell Manufacturing Businessreportable segmentsegment assetsat 2022-09-30¥643m
Contracted Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2022-09-30−¥233m
—segment totalcapex2021-10-01 → 2022-09-30¥64m
—segment totaldepreciation2021-10-01 → 2022-09-30¥84m
—segment totalrevenue2021-10-01 → 2022-09-30¥634m
—segment totalrevenue external2021-10-01 → 2022-09-30¥634m
—segment totalsegment assetsat 2022-09-30¥790m
—segment totalsegment profit2021-10-01 → 2022-09-30−¥815m
Reconciling Itemsreconcilingcapex2020-10-01 → 2021-09-30¥8m
Reconciling Itemsreconcilingdepreciation2020-10-01 → 2021-09-30¥23m
Reconciling Itemsreconcilingsegment assetsat 2021-09-30¥4.6bn
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-09-30−¥497m
Cellular And Tissue Based Product Businessreportable segmentcapex2020-10-01 → 2021-09-30¥7m
Cellular And Tissue Based Product Businessreportable segmentdepreciation2020-10-01 → 2021-09-30¥34m
Cellular And Tissue Based Product Businessreportable segmentrevenue2020-10-01 → 2021-09-30¥206,000
Cellular And Tissue Based Product Businessreportable segmentrevenue external2020-10-01 → 2021-09-30¥206,000
Cellular And Tissue Based Product Businessreportable segmentsegment assetsat 2021-09-30¥157m
Cellular And Tissue Based Product Businessreportable segmentsegment profit2020-10-01 → 2021-09-30−¥451m
Contracted Cell Manufacturing Businessreportable segmentcapex2020-10-01 → 2021-09-30¥18m
Contracted Cell Manufacturing Businessreportable segmentdepreciation2020-10-01 → 2021-09-30¥58m
Contracted Cell Manufacturing Businessreportable segmentrevenue2020-10-01 → 2021-09-30¥683m
Contracted Cell Manufacturing Businessreportable segmentrevenue external2020-10-01 → 2021-09-30¥683m
Contracted Cell Manufacturing Businessreportable segmentsegment assetsat 2021-09-30¥666m
Contracted Cell Manufacturing Businessreportable segmentsegment profit2020-10-01 → 2021-09-30−¥132m
—segment totalcapex2020-10-01 → 2021-09-30¥25m
—segment totaldepreciation2020-10-01 → 2021-09-30¥92m
—segment totalrevenue2020-10-01 → 2021-09-30¥683m
—segment totalrevenue external2020-10-01 → 2021-09-30¥683m
—segment totalsegment assetsat 2021-09-30¥824m
—segment totalsegment profit2020-10-01 → 2021-09-30−¥583m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,053
ItemContextValueUnit
Operating incomeCurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember-815256000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember-517843000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-1333099000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05351-000ContractedCellManufacturingBusinessReportableSegmentsMember643150000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember146950000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember790101000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_ReconcilingItemsMember5287960000JPY
AssetsCurrentYearInstant_NonConsolidatedMember6078061000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E05351-000ContractedCellManufacturingBusinessReportableSegmentsMember56498000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember27761000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember84259000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember21600000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember105859000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E05351-000ContractedCellManufacturingBusinessReportableSegmentsMember59590000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember4033000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember63623000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember13371000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember76994000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-12-15
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第27期（自　2021年10月１日　至　2022年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社メディネット
Company name in english cover pageFilingDateInstantMEDINET Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　久布白　兼直
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都品川区勝島一丁目５番21号（同所は登記上の本店所在地であり、実際の業務は「最寄りの連絡場所」で行っております。）
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)該当事項はありません。
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)該当事項はありません。
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都大田区平和島六丁目１番１号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)（０３）６６３１－１２０１（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役経営管理部長　落合　雅三
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE05351
Fund codeFilingDateInstant－
Security codeFilingDateInstant23700
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社メディネット
Filer name in englishFilingDateInstantMEDINET Co., Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2021-10-01
Current period end dateFilingDateInstant2022-09-30
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2022-09-30

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-09-30pass rounding
balance sheet identitynon_consolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-09-30pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2021-09-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass